Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says
Swiss pharmaceutical giant Novartis said Wednesday that it does not plan to enter into the "frenzy" of weight loss drugs.
Read More
Novartis AG
Stocks making the biggest moves midday: GameStop, Viking Therapeutics, Trump Media and more
These are the stocks posting the largest moves in midday trading. Source link
Read More
Wednesday’s market calls: Morgan Stanley downgraded, home goods stock to pop nearly 20%
A major U.S. bank and a home goods company were among the companies being talked about by analyst on Wednesday.
Read More
Here Tuesday’s the biggest analyst calls: Nvidia, Apple, Broadcom, Boeing, Bank of America, IBM, Meta, Uber & more
Here are the biggest calls on Wall Street on Source link
Read More
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
It is a milestone in a controversial process that aims to make costly medications more affordable for older Americans but
Read More
Strong yen beneficiaries and more: Consider these buying opportunities amid the volatility, the pros say
"But I think what we're seeing here is a temporary issue that will present some really good, longer term chances,"
Read More
This up-and-coming cancer treatment could be a $25 billion market opportunity — it’s already a hotbed for M&A
Targeted radiopharmaceuticals, which deliver radiation directly into tumors, has caught the eye of big pharma. Source link
Read More
A corner of the cancer therapy market is heating up—Here are the names investors need to know
Radiopharmaceuticals seek to destroy cancer cells by binding a radioactive particle to a targeted molecule and then dispatching it directly
Read More
Stocks making the biggest moves midday: Spotify, JetBlue, Danaher, General Motors and more
These are the stocks posting the largest moves in midday trading. Source link
Read More